STOCK TITAN

Planned sale of 13,109 Company (NASDAQ: CGON) shares disclosed in filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CGON filed a notice of proposed sale of restricted or control securities. The filing covers the planned sale of 13,109 common shares, with an aggregate market value of $549,660.37, through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/09/2026. The issuer had 80,666,179 common shares outstanding. The shares to be sold were acquired on 01/09/2026 by exercising stock options granted by the issuer, paid for in cash on the same date.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the CGON Form 144 filing disclose?

The Form 144 discloses a planned sale of 13,109 shares of CGON common stock, acquired via stock option exercise and proposed to be sold on NASDAQ through a broker.

How many CGON shares are planned to be sold and what is their value?

The notice covers 13,109 common shares with an aggregate market value of $549,660.37.

How were the CGON shares being sold under Form 144 acquired?

The shares were acquired on 01/09/2026 through an exercise of stock options from the issuer, with the purchase price paid in cash on the same date.

Which broker is handling the planned CGON share sale?

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, New York, NY 10004.

On which exchange are the CGON shares intended to be sold?

The filing indicates that the common shares are intended to be sold on the NASDAQ stock market.

How many CGON shares were outstanding at the time referenced in the filing?

The Form 144 states that there were 80,666,179 common shares outstanding for the issuer.

What is the approximate date of the planned CGON share sale in this Form 144?

The approximate date of sale listed for the 13,109 common shares is 01/09/2026.

CG Oncology, Inc.

NASDAQ:CGON

CGON Rankings

CGON Latest News

CGON Latest SEC Filings

CGON Stock Data

4.28B
73.31M
1.17%
112.6%
13.42%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
IRVINE